Compare SGHT & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGHT | PNNT |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.5M | 397.7M |
| IPO Year | 2021 | 2007 |
| Metric | SGHT | PNNT |
|---|---|---|
| Price | $6.90 | $6.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $8.23 | $5.95 |
| AVG Volume (30 Days) | 329.1K | ★ 602.6K |
| Earning Date | 03-04-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 15.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | $76,052,000.00 | ★ $122,377,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.07 | N/A |
| P/E Ratio | ★ N/A | $12.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $5.66 |
| 52 Week High | $9.24 | $7.53 |
| Indicator | SGHT | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 58.31 |
| Support Level | $6.39 | $5.89 |
| Resistance Level | $7.55 | $6.18 |
| Average True Range (ATR) | 0.60 | 0.12 |
| MACD | -0.19 | 0.03 |
| Stochastic Oscillator | 17.04 | 98.75 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.